Evidence map›Paper›PMID 23549398›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2013

Squamous dysplasia--the precursor lesion for esophageal squamous cell carcinoma.

Philip R Taylor, Christian C Abnet, Sanford M Dawsey

3 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
7.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00341523 terminatednot on this mapstarted 2016, after this paper: background citation

Early Detection of Esophageal Cancer

TypeobservationalSponsorNational Cancer Institute (NCI)Ran2016 to 2024Enrolled6,864ConditionsEsophageal Neoplasms, Stomach Neoplasms, Endoscopy, Gastrointestinal, Digestive System Endoscopic Surgical Procedures
NCT02311712 nasuspendednot on this mapstarted 2016, after this paper: background citation

Non-endoscopic Esophageal Cancer Screening Program in Northern Iran

TypeinterventionalSponsorTehran University of Medical SciencesRan2016 to 2029Enrolled12,000ConditionsEsophageal CancerArmsCapsule sponge
NCT04843397 unknown statusnot on this mapstarted 2021, after this paper: background citation

PROspective Multicentre Study to Identify Diagnostic Key PERfOrmance Indicators in Upper GI Endoscopy (PROSPERO)

TypeobservationalSponsorUniversity of CambridgeRan2021 to 2022Enrolled1,000ConditionsEsophageal Cancer, Gastric Cancer, Barrett Esophagus, Gastric Atrophy
3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 164 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Advanced Endoscopic Techniques to Detect Prevalence of Synchronous Oesophageal Cancers in Patients with Head and Neck Cancers.Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Philip R TaylorNational Cancer Institute, NIH, EPS, 6120 Executive Blvd, Rm 7006, Bethesda, MD 20892, USA. ptaylor@mail.nih.gov
Christian C Abnet
Sanford M Dawsey
National Cancer Institute · USDivision of Cancer Epidemiology and Genetics

Funding

Upper Gastrointestinal Cancer StudiesZIACP000185 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ABNET, CHRISTIAN · 2009 to 2025
$25.6M
Nutrition Intervention Trials in Linxian ChinaZIACP000112 · NCI · DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS · PI ABNET, CHRISTIAN · 2009 to 2025
$8.2M
Intramural NIH HHS ZIA CP000112Intramural NIH HHS ZIA CP000185
6 · The paper itself

Abstract

Esophageal squamous cell carcinoma (ESCC) accounts for 80% of all esophageal cancers worldwide, and esophageal squamous dysplasia (ESD) is the only histopathology that predicts the development of ESCC. The prevalence of ESD parallels rates of invasive ESCC and is typically found in 25% or more of adults above the age of 35 years in populations in north central China, where risk for ESCC is among the highest in the world. Results of chemoprevention and early detection studies to prevent progression of ESD suggest that these approaches, coupled with emerging endoscopic therapies, offer promise for the prevention of esophageal cancer mortality in high-risk populations. Future research on ESD and ESCC should focus on finding additional modifiable risk factors and on identifying biomarkers to incorporate into early detection strategies.

Indexed as

AdultCarcinoma, Squamous CellChinaDisease ProgressionEsophageal NeoplasmsEsophagusHumansHyperplasiaPrecancerous ConditionsRisk Factors

Identifiers

PMID23549398
PMCPMC3681095
OpenAlexW2118705635

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.